Citi downgraded Corteva (CTVA) to Neutral from Buy with a price target of $67, down from $83, following the company’s plan to spin-off its Seeds business. JPMorgan upgraded Corteva this morning. Citi sees a challenging 2026 setup for the shares as it does not believe the separation will unlock additional shareholder value. The company’s brings more uncertainty amid adds an uncertain macro backdrop, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva upgraded to Overweight from Neutral at JPMorgan
- Corteva’s Strategic Split: Unlocking Value and Growth Potential with a Buy Rating
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Corteva to separate into two publicly traded companies
- Oppenheimer maintains bullish stance on Corteva following split reports